OpenBilldrug price receipt

NADAC week of 2026-10-14

OMNARIS 50 MCG NASAL SPRAY

FDA nonproprietary name: ciclesonide

For 1 g

Pharmacies pay

$22.55 filed

1 × $22.5531 per GM

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$22.87 filed

1 × $22.87264 per GM, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

1.0× estimated

Medicare paid about what pharmacies pay.

Part D averages every strength and form sold under “Omnaris” / “Ciclesonide” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$30.93 estimated

$22.55 + $3.38 (15%) + $5.00 fee per fill = $30.93

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

OMNARIS 50 MCG NASAL SPRAY is how the CMS NADAC file names this product. The FDA NDC Directory lists it as ciclesonide, under the trade name “Omnaris”.

FDA gives its dosage form as spray and its route as nasal.

The labeler, the company named on the label, is Covis Pharma US, Inc.

FDA lists no Established Pharmacologic Class for it.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 70515-0701-01.

NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $22.55 for 1 g (1 × $22.5531 per GM, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.

The NDC

Other strengths, forms and brands

2 other products in the NADAC file share the FDA nonproprietary name ciclesonide with OMNARIS 50 MCG NASAL SPRAY.

ProductPharmacies pay per unitMedicare per unit
ALVESCO 80 MCG INHALER
brand · aerosol, metered
$42.95871 per GM filed
eff. 2026-09-23
We don’t know yet
ALVESCO 160 MCG INHALER
brand · aerosol, metered
$42.97099 per GM filed
eff. 2026-09-23
We don’t know yet
OMNARIS 50 MCG NASAL SPRAY this page
brand · spray
$22.5531 per GM filed
eff. 2026-09-23
$22.87264 per GM filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

What Medicare paid

Medicare Part D paid $22.87 for 1 g, at an average of $22.87264 per GM in 2024 (2024-01-01 to 2024-12-31) for “Omnaris” and “Ciclesonide”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 1,855 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for OMNARIS 50 MCG NASAL SPRAY labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Omnaris / Ciclesonide: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's GM. Joined on brand name.
Why does this page start at 1 g?
The FDA package description of NDC 70515-0701-01 (“1 POUCH in 1 CARTON (70515-701-01) / 1 BOTTLE, GLASS in 1 POUCH / 120 SPRAY in 1 BOTTLE, GLASS”) does not give one amount in g, NADAC’s unit for this product. So the card starts at 1 GM; change it to match your prescription.